The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

The US Food and Drug Administration has cleared the Abbott Libre 2 and 3 continuous glucose monitoring ... due to concern that the exposure could potentially damage the sensor and lead to incorrect ...

FreeStyle Libre 2 sensors will be phased out in the UK by the end of August 2025, meaning that people living with diabetes who use the sensors will need to transition to using FreeStyle Libre 2 Plus ...

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & ...

Insulet is making significant strides in its key strategic imperatives to help patients manage diabetes efficiently. The ...

The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets.

Canadians living with type 2 diabetes can feel anxious and overwhelmed due to the constant demands of managing their condition, alongside everyday responsibilities. The diabetes experience is one that ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

Today, she's a spunky 9-year-old. Abbott Enters U.S. Consumer Biowearables Market With Lingo and Libre Rio Recent FDA clearance of two new over-the-counter continuous glucose monitoring systems ...

Through Abbott's proprietary i2i™ (implant-to-implant) communication technology, AVEIR DR devices provide synchronized cardiac pacing between two leadless pacemakers. During the CIIE, the company will ...